news

Dietary supplement may carry both benefits and risks associated with statins

0
SHARES

Posted: 18 January 2017 | Wiley | No comments yet

Red yeast rice (RYR) is contained in dietary supplements that are often used by patients with high cholesterol as an alternative…

red-yeast-rice-statins

Red yeast rice (RYR) is contained in dietary supplements that are often used by patients with high cholesterol, and it is often proposed as an alternative therapy in those who experience side effects from statins.

red-yeast-rice-statins

A new study found that it is not a good choice for statin-intolerant patients: RYR was linked with muscle and liver injury, which can also occur with statin use.

The beneficial effects of RYR are ascribed to monacolins, which are chemically related to statins.

 

Reserve your FREE place

 

 

Free webinar: Fermentation elevated: precision analytics with mass spectrometry in the biofood revolution

This webinar will explore how precision analytic technologies like automated mass spectrometry are transforming fermentation in biofood production and can elevate your operations with greater efficiency, consistency and scalability.

Speaker:

Daniel Merriman – Product Expert for Mass Spectrometry at Thermo Fisher Scientific

REGISTER A FREE PLACE NOW!

The study’s authors note that statins are prescribed under medical control, and blood tests are periodically performed so that statin use can be stopped as soon as abnormal results are identified. On the contrary, RYR is used as self-prescription, without medical advice and monitoring, so patients risk experiencing toxic effects that may go unnoticed.

“The proportion of serious reports (27%), the relatively rapid time to onset and the lack of concomitant drugs and/or predisposing medications in several cases warrants regulatory consideration and call for:

1) continuous monitoring of “natural” dietary supplements safety through spontaneous reports;

2) appropriate information to clinicians and consumers, who should timely submit suspect reports to regulatory Agencies,” wrote the authors of the British Journal of Clinical Pharmacology study.

Related topics

Leave a Reply

Your email address will not be published. Required fields are marked *

Share via
Share via